Home » Tuberculosis Diagnostics Firm Oxford Immunotec Limited Files for $86 Million IPO
Tuberculosis Diagnostics Firm Oxford Immunotec Limited Files for $86 Million IPO
Oxford Immunotec Global filed with the SEC to raise up to $86 million in an initial public offering. The Abingdon, UK-based company plans to list on the NASDAQ.
DeviceSpace
DeviceSpace
Upcoming Events
-
23May
-
30May
-
13Jun
-
20Jun
-
21Oct